You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Learning-based Threat Classification and Localization Using Infrared Imaging and Ion Mobility Spectrometry

    SBC: KEF ROBOTICS INC            Topic: CBD212001

    Concealed chemical threats represent a significant hazard to field operators. Even brief exposure to chemicals can cause lasting physical, physiological, and mental damage. Field operators require tools and techniques to more quickly, safely, and reliably locate and identify chemical threats. Chemical detectors typically excel at either threat classification or threat localization, but seldom both ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  2. Ruggedized Spray on Antimicrobial Wound Dressing for Treatment of Multiple Sulfur Mustard-Induced Dermal Injuries in Theater to Mitigate Infection, Pain and Promote Healing

    SBC: KERICURE INC            Topic: CBD212005

    Field Shield Wound Dressing (FSWD) is a novel wound dressing that takes an innovative approach to addressing major wounds, both in prolonged field care and throughout the continuum of care. It is the first wound dressing to combine an effective broad spectrum antimicrobial (nanosilver) with a local anesthetic (lidocaine) in a simple to apply point-and-spray wound dressing. A patented polyacrylate ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  3. Formulation and analytical development of a multi-dose vial presentation of scopolamine hydrobromide trihydrate containing a antimicrobial preservatives (AMP)

    SBC: CMC PHARMACEUTICALS INC            Topic: CBD212004

    The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical is developing scopolamine hydrobromide trihydrate (Scop-HBT) under the Improved Nerve Agent Treatment System - Centrally Acting program. Scop-HBT is an anticholinergic medical countermeasure that temporarily blocks severe or life-threatening muscarinic effects caused by organophosphorus nerve agent (OPNA) poisoni ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  4. Phase Sensitive Millimeter Wave Imaging with Metamaterials

    SBC: SRICO INC            Topic: CBD213002

    SRICO proposes state-of-the-art metamaterial based sensing technology to coherent hyperspectral imaging in the W-band portion of the MMW spectrum. The metamaterial absorber pixel design provides spectrally tailored and phase sensitive vector mode sensing capability critical for W-band imaging. The proposed imaging array features spectrally tailored and deeply sub-wavelength size metamaterial pixel ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  5. HoloWarriorTM Augmented Reality CBRN Threat Display for Mounted Situational Awareness

    SBC: VR REHAB INC            Topic: CBD212002

    VRR’s HoloWarrior™ augmented reality Heads Up Display for HoloLens 2/IVAS (Android, Windows) is TRL 7 with multiple successful SBIR use cases developed such as real-time visualizations for Marine JTACs, amphibious vehicle operators, and sUAS pilots. Under funding from OSD/Army (CCDC-SC) real-time visualizations already developed includes detected radio emitters and threat/targets with localiza ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  6. Field Portable Mass Spectrometry for Small Molecule Drugs in Clinical Samples

    SBC: SPECTRAL ENERGIES LLC            Topic: CBD181006

    We propose a novel two-dimensional mass spectrometry (2D-MS) technique based on ion trap arrays to identify illicit and designer drugs. This approach will give an unprecedented multiplex advantage for miniature mass spectrometry, allowing novice field technicians to rapidly identify drugs affecting the central nervous system based on both the m/z ratio and fragmentation pattern of an ion. Towards ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  7. Dual Formulation of Atropine/Scopolamine with Enhanced Stability

    SBC: CMC PHARMACEUTICALS INC            Topic: CBD181005

    CMC Pharmaceuticals, Inc. (Cleveland, OH) is proposing developing a stable, combination product of two small molecule drug candidates as a counter measure to chemical warfare nerve agents (NA). The combination product is expected to exploit complementary pharmacological profiles for optimal muscarinic receptor blockade and anticholinergic activity within the peripheral and central nervous system. ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  8. Host-Targeted Antiviral Drugs Providing Rapid, Scalable, Stable, Broad-Spectrum MedicalCountermeasure Against Marburg Virus

    SBC: EVRYS BIO LLC            Topic: CBD18A002

    In a pandemic or exposure to weaponized Marburg virus the morbidity, mortality and social unrest that will ensue before vaccines orMilitary operating on foreign soil as well as to the population of the US Homeland. Practically all threat agents of biological origin (except forcertain non-proteinaceous toxins, typically produced by marine organisms and fungi) have their structure and vital function ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  9. Circulating Diagnostic Markers of Infectious Disease

    SBC: PATHOVACS INCORPORATED            Topic: CBD18A001

    The focus of this STTR phase I component is on proof-of-concept studies demonstrating applicability of technical approaches for identificationof circulatory diagnostic markers for infectious disease. Therefore, the primary objective of this project is to determine feasibility of one suchtechnical approach called Proteomics-based Expression Library Screening (PELS), for identification of pathogen-d ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  10. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD RESEARCH CORPORATION            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government